Company intelligence / Profile preview

Acino

Zurich, Zurich, Switzerlandch.linkedin.com ↗

Ownership: Private
Employees: ~2848
Development stage: Commercial

Overview

Acino focuses on developing and marketing well-proven and innovative pharmaceuticals, particularly in high-growth markets. It has a strong presence in novel drug delivery systems.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularMen's HealthRheumatologyWomen's HealthOncologyNeurologyInfectious Diseases
Modalities: Small moleculesmodified-release oral formsdispersible forms
Industry: Biotech

Partnerships

Partnerships for product development, manufacturing, and distribution

Beyond the preview

Go deeper on Acino.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acino.

Explore the full profile